125 related articles for article (PubMed ID: 10704794)
1. Transdermal iontophoretic delivery of timolol maleate in albino rabbits.
Kanikkannan N; Singh J; Ramarao P
Int J Pharm; 2000 Mar; 197(1-2):69-76. PubMed ID: 10704794
[TBL] [Abstract][Full Text] [Related]
2. In vitro transdermal iontophoretic transport of timolol maleate: effect of age and species.
Kanikkannan N; Singh J; Ramarao P
J Control Release; 2001 Mar; 71(1):99-105. PubMed ID: 11245911
[TBL] [Abstract][Full Text] [Related]
3. Transdermal delivery of timolol by electroporation through human skin.
Denet AR; Préat V
J Control Release; 2003 Mar; 88(2):253-62. PubMed ID: 12628332
[TBL] [Abstract][Full Text] [Related]
4. Transdermal delivery of timolol and atenolol using electroporation and iontophoresis in combination: a mechanistic approach.
Denet AR; Ucakar B; Préat V
Pharm Res; 2003 Dec; 20(12):1946-51. PubMed ID: 14725358
[TBL] [Abstract][Full Text] [Related]
5. Iontophoretic enhancement of timolol across human dermatomed skin in vitro.
Fatouros DG; Bouwstra JA
J Drug Target; 2004 Jan; 12(1):19-24. PubMed ID: 15203908
[TBL] [Abstract][Full Text] [Related]
6. The role of hyaluronan as a drug carrier to enhance the bioavailability of extended release ophthalmic formulations. Hyaluronan-timolol ionic complexes as a model case.
Battistini FD; Tártara LI; Boiero C; Guzmán ML; Luciani-Giaccobbe LC; Palma SD; Allemandi DA; Manzo RH; Olivera ME
Eur J Pharm Sci; 2017 Jul; 105():188-194. PubMed ID: 28506871
[TBL] [Abstract][Full Text] [Related]
7. Iontophoretic in vivo transdermal delivery of beta-blockers in hairless rats and reduced skin irritation by liposomal formulation.
Conjeevaram R; Chaturvedula A; Betageri GV; Sunkara G; Banga AK
Pharm Res; 2003 Sep; 20(9):1496-501. PubMed ID: 14567646
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular effects of transdermally delivered bupranolol in rabbits: effect of chemical penetration enhancers.
Babu RJ; Dhanasekaran M; Vaithiyalingam SR; Singh PN; Pandit JK
Life Sci; 2008 Jan; 82(5-6):273-8. PubMed ID: 18096189
[TBL] [Abstract][Full Text] [Related]
9. Discoidal niosome based controlled ocular delivery of timolol maleate.
Vyas SP; Mysore N; Jaitely V; Venkatesan N
Pharmazie; 1998 Jul; 53(7):466-9. PubMed ID: 9742041
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate.
El-Kamel AH
Int J Pharm; 2002 Jul; 241(1):47-55. PubMed ID: 12086720
[TBL] [Abstract][Full Text] [Related]
11. In vitro evaluation of a hydroxypropyl cellulose gel system for transdermal delivery of timolol.
Stamatialis DF; Rolevink HH; Gironès M; Nymeijer DC; Koops GH
Curr Drug Deliv; 2004 Oct; 1(4):313-9. PubMed ID: 16305393
[TBL] [Abstract][Full Text] [Related]
12. New mucoadhesive chitosan film for ophthalmic drug delivery of timolol maleate: in vivo evaluation.
Fulgêncio Gde O; Viana FA; Ribeiro RR; Yoshida MI; Faraco AG; Cunha-Júnior Ada S
J Ocul Pharmacol Ther; 2012 Aug; 28(4):350-8. PubMed ID: 22320419
[TBL] [Abstract][Full Text] [Related]
13. Bioavailability of timolol and aceclidine after ocular instillation in the rabbit.
Matera MG; Lampa E; Imperatore A; Berrino L; Russo F; Boldrini E; Rossi F
Res Commun Mol Pathol Pharmacol; 1998 Apr; 100(1):35-42. PubMed ID: 9644717
[TBL] [Abstract][Full Text] [Related]
14. Comparison between the iontophoretic and passive transdermal delivery of timolol maleate across human cadaver skin.
Soni S; Dixit VK
Pharmazie; 1994 Jan; 49(1):73-4. PubMed ID: 8140139
[No Abstract] [Full Text] [Related]
15. Improved ocular absorption kinetics of timolol maleate loaded into a bioadhesive niosomal delivery system.
Kaur IP; Aggarwal D; Singh H; Kakkar S
Graefes Arch Clin Exp Ophthalmol; 2010 Oct; 248(10):1467-72. PubMed ID: 20437246
[TBL] [Abstract][Full Text] [Related]
16. Controlled transport of timolol maleate through artificial membranes under passive and iontophoretic conditions.
Stamatialis DF; Rolevink HH; Koops GH
J Control Release; 2002 Jun; 81(3):335-45. PubMed ID: 12044572
[TBL] [Abstract][Full Text] [Related]
17. Continuous monitoring of circadian variations in intraocular pressure by telemetry system throughout a 12-week treatment with timolol maleate in rabbits.
Akaishi T; Ishida N; Shimazaki A; Hara H; Kuwayama Y
J Ocul Pharmacol Ther; 2005 Dec; 21(6):436-44. PubMed ID: 16386085
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic and pharmacodynamic analysis of systemic effect of topically applied timolol maleate ophthalmic gelling vehicle (Rysmon TG).
Ohno Y; Iga T; Yamada Y; Nagahara M; Araie M; Takayanagi R
Curr Eye Res; 2005 Apr; 30(4):319-28. PubMed ID: 16020262
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamic effects of transdermal bupranolol and timolol in vivo: comparison of microemulsions and matrix patches as vehicle.
Kemken J; Ziegler A; Müller BW
Methods Find Exp Clin Pharmacol; 1991 Jun; 13(5):361-5. PubMed ID: 1921573
[TBL] [Abstract][Full Text] [Related]
20. Physicochemical and pharmacological investigation of water/oil microemulsion of non-selective beta blocker for treatment of glaucoma.
Hegde RR; Bhattacharya SS; Verma A; Ghosh A
Curr Eye Res; 2014 Feb; 39(2):155-63. PubMed ID: 24073659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
